ongoing

The DANCE Vanguard trial will compare the safety of direct oral anticoagulants (DOAC) versus vitamin K antagonists (VKA) in the early period (30 days) after cardiac surgery in patients with an indication for oral anticoagulation.

The SUNDANCE trial – which is a sub-study of the DANCE trial – focuses on subclinical valve thrombosis in patients with bioprosthetic aortic and/or mitral valve replacement.

DANCE and SUNDANCE substudy - Download PDF
Study Type

Interventional - Drug

Study Design

Multi-centre, open randomized controlled trial

NO. of Countries

4

NO. of Sites

25

NO. of Participants

800

Study Period

2021 - 2027

Sponsor

PHRI

Canadian Cardiovascular Society

Early Career Arrhythmia and Atrial Fibrillation Award (ECA3)

McMaster Surgical Associates

Back To Top